# Comparison of 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Frequency

> **NCT06266000** · PHASE4 · COMPLETED · sponsor: **RDC Clinical Pty Ltd** · enrollment: 89 (actual)

## Conditions studied

- Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Saw palmetto extract 320mg per day
- **DRUG:** Commercial Saw palmetto extract 320mg per day
- **DRUG:** Palm Oil capsule

## Key facts

- **NCT ID:** NCT06266000
- **Lead sponsor:** RDC Clinical Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-21
- **Primary completion:** 2025-06-04
- **Final completion:** 2025-06-04
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2025-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06266000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06266000, "Comparison of 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Frequency". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06266000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*